Archives
-
Thiazovivin: ROCK Inhibitor Workflow Guide
2026-09-03
Thiazovivin (SKU A5506) is a ROCK inhibitor used to support fibroblast reprogramming and human embryonic stem cell survival after trypsinization. It is intended for controlled stem cell research workflows only, not diagnostic, clinical, or therapeutic use, and the dossier does not define a universal working concentration or exposure time.
-
Eltanexor (KPT-8602) XPO1 Research Workflow
2026-09-02
Build reproducible XPO1 inhibition experiments with Eltanexor (KPT-8602), from DMSO handling and dose-response design to nuclear-retention and organoid assays. The workflow connects hematologic cancer models with emerging colorectal chemoprevention data while separating established product specifications from practical starting recommendations.
-
Gasdermin C Reprograms PDAC Stemness and Immunity
2026-09-02
The 2024 Advanced Science study identifies GSDMC as a nuclear regulator of stemness, epithelial–mesenchymal transition, metastasis, and immune evasion in pancreatic ductal adenocarcinoma, independent of pyroptotic cell death. Its mechanistic findings connect ADAM17-mediated cleavage and nuclear translocation of GSDMC to treatment resistance and suggest a route for improving responses to KRASG12D inhibition and PD-1 blockade.
-
2X HyperFusion High-Fidelity Master Mix for PCR
2026-09-01
2X HyperFusion High-Fidelity Master Mix is a ready-to-use formulation for high accuracy DNA amplification, cloning PCR applications, and difficult amplicons. Its HyperFusion high-fidelity DNA polymerase combines processivity with 3′→5′ proofreading and produces blunt-ended PCR products, while supplier-stated performance claims should be verified under the user’s own reaction conditions.
-
5-Azacytidine Reprograms Dormant Cancer Cells
2026-09-01
The 2023 Cell Reports study shows that 5-Azacytidine combined with all-trans retinoic acid or an RARα agonist can reprogram disseminated cancer cells into a stable dormant state rather than simply eliminating them. The effect depends on restored TGF-β–SMAD4 signaling and suppresses metastatic outgrowth in preclinical head and neck cancer models, providing a mechanistic framework for studying metastasis prevention through epigenetic therapy.
-
GPC3-HSP70 mRNA Vaccine and PD-L1 Blockade
2026-08-31
The reference study develops a targeted mRNA nanovaccine encoding tandem GPC3 cytotoxic T-lymphocyte epitopes fused to HSP70 and shows enhanced antitumor immunity when combined with anti-PD-L1 therapy. Its significance lies in integrating tumor-associated antigen selection, HSP70-mediated immune stimulation, SP94-guided delivery, and checkpoint blockade within one preclinical HCC strategy.
-
Cisplatin, m6A, and DNA-Repair Vulnerability
2026-08-31
Cisplatin is more than a cytotoxic endpoint: it is a mechanistic probe for how RNA regulation, DNA repair, and apoptotic commitment intersect. This thought-leadership framework connects CDDP response biology with findings on the arginine methylation-dependent METTL14–SMN interaction, while distinguishing evidence-supported insight from translational hypotheses.
-
Rapid Microwave Heating Preserves Lactoferrin Function
2026-08-30
The reference study separates microwave-specific effects from heating-rate effects by comparing microwave, conventional thermal, and microwave-simulated thermal processing of lactoferrin. Its findings indicate that rapid passage through the denaturation range better preserves lactoferrin structure, limits aggregation, and maintains antioxidant, anti-inflammatory, and anti-apoptotic activity.
-
PRMT5 Links Splicing to MYCN Neuroblastoma Metabolism
2026-08-29
Bojko and colleagues show that MYCN-amplified neuroblastoma depends on PRMT5-mediated control of RNA splicing, epitranscriptomic regulation, and glutamine metabolism. Their integrated cellular, transcriptomic, isotope-tracing, and mouse studies identify reduced GLS protein and disrupted nutrient sensing as important consequences of PRMT5 inhibition, providing a mechanistic framework for studying metabolic vulnerability in high-risk neuroblastoma.
-
EZ Cap™ Cy5 EGFP mRNA (5-moUTP) Workflow
2026-08-28
Separate nanoparticle uptake from productive translation with a dual-fluorescence reporter that tracks Cy5 cargo and EGFP expression in the same cells. This practical workflow shows how to validate targeted LNPs, optimize delivery conditions, and troubleshoot discordant fluorescence results.
-
Annexin V-Cy5/DAPI Apoptosis Kit: Assay Logic
2026-08-28
The Annexin V-Cy5/DAPI Apoptosis Kit connects phosphatidylserine exposure with membrane integrity for rapid apoptosis and necrosis differentiation. This guide translates findings from a Ph+ ALL apoptosis study into practical assay design, controls, interpretation, and orthogonal validation.
-
NMDA as a Translational Lens on Excitotoxicity
2026-08-27
NMDA (N-Methyl-D-aspartic acid) is more than a receptor agonist: it is a controlled perturbation for connecting calcium influx, oxidative stress, ferroptosis-associated signaling, and neuronal loss. This thought-leadership guide links NMDA-based glaucoma modeling with BMP4-GPX4 findings and offers a practical framework for reproducible excitotoxicity research, assay design, and translational interpretation.
-
Perospirone: Receptor and Kv Channel Workflow
2026-08-27
Perospirone (SM-9018 free base) supports a unified workflow for studying receptor pharmacology and vascular potassium-channel off-target effects. Its nanomolar serotonergic and dopaminergic activity can be experimentally separated from micromolar Kv1.5-related inhibition, helping researchers build more informative schizophrenia and cardiovascular assays.
-
Hypoxia, Immunometabolism, and Tumor Immune Escape
2026-08-26
This review integrates tumor hypoxia with metabolic competition and immune-cell dysfunction to explain how the tumor microenvironment becomes immunosuppressive. Its main practical value is a systems-level framework for designing studies that measure oxygen status, nutrient use, immune phenotype, and redox changes together rather than as isolated variables.
-
Cy3 Goat Anti-Rabbit IgG (H+L) Antibody
2026-08-26
Cy3 Goat Anti-Rabbit IgG (H+L) Antibody provides fluorescent detection of rabbit IgG primary antibodies in immunofluorescence, immunohistochemistry, immunocytochemistry, and flow cytometry workflows. This dossier-based guide covers handling, controls, optimization, and limitations; it should not be treated as evidence of diagnostic performance or as validation for live-cell use without additional testing.